| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.07 |